| Literature DB >> 35401768 |
Monique Mendelson1, Samarmar Chacaroun1, Sébastien Baillieul1, Stéphane Doutreleau1, Michel Guinot1, Bernard Wuyam1, Renaud Tamisier1, Jean-Louis Pépin1, François Estève2, Damien Tessier3, Samuel Vergès1, Patrice Flore1.
Abstract
Background: Considering the potential greater cardiocirculatory effects of high intensity interval training (HIIT), we hypothesized that a 2-month supervised high volume short interval HIIT would induce greater improvements in CRF and cardiometabolic risk and increase long-term maintenance to physical activity compared to isocaloric moderate intensity continuous training (MICT) in overweight/obesity.Entities:
Keywords: Cardiometabolic risk; Exercise; High intensity interval training; Long term adherence; Moderate intensity continuous training; Overweight/obesity
Year: 2022 PMID: 35401768 PMCID: PMC8956941 DOI: 10.1016/j.jesf.2022.03.001
Source DB: PubMed Journal: J Exerc Sci Fit ISSN: 1728-869X Impact factor: 3.103
Fig. 1Flow chart of the study design.
Patient characteristics of the three groups.
| MICT | HIIT | HIIT-RM | |
|---|---|---|---|
| n = 20 | n = 20 | n = 20 | |
| Gender, M/F | 17/3 | 16/4 | 14/6 |
| Age, years | 51 ± 11 | 52 ± 8 | 54 ± 9 |
| Body mass Index, kg·m−2 | 31.8 ± 3.2 | 31.3 ± 3.1 | 31.2 ± 2.9 |
| Metabolic syndrome, % | 68.2 | 77.8 | 66.7 |
| Angiotensin II blockers | 3 | 5 | 3 |
| Conversion enzyme blocker | 2 | – | – |
| β-blockers | 2 | 1 | 1 |
| Calcium antagonists | 1 | 1 | – |
| Diuretic | 2 | 2 | 1 |
| Statins | 2 | 2 | 2 |
| Lipid lowering | 1 | – | – |
| Platelet anti-aggregating agent | 5 | 1 | 1 |
| Metformin | 2 | 3 | 1 |
| Anti-depressant | 4 | – | – |
| CPAP | 15 | 14 | 10 |
Data are presented as mean ± SD or number of patients (n) when appropriate. CPAP: Continuous positive airway pressure.
Anthropometrics’ data, body composition and liver fat throughout the protocol in the four groups of subjects.
| Weight | WC | HC | Fat mass | LM | Leg muscular mass | Abdominal FM | Visceral Fat surface | Liver fat mass | |
|---|---|---|---|---|---|---|---|---|---|
| kg | cm | cm | kg | kg | kg | kg | cm | % | |
| T0 | 104.2 ± 25.2 | 114.5 ± 14.2 | 113.7 ± 18.2 | 39.3 ± 17.3 | 64.9 ± 15.0 | 15.9 ± 3.8 | 12.2 ± 4.4 | 178.4 ± 67.7 | 15.6 ± 11.0 |
| T2 | 104.1 ± 25.0 | 113.8 ± 14.4 | 112.2 ± 18.0∗ | 39.3 ± 17.1 | 64.8 ± 14.9 | 16.2 ± 3.8 | 10.8 ± 4.3 | 182.4 ± 71.2 | 14.8 ± 10.2 |
| T6 | 103.4 ± 24.9 | 112.8 ± 14.7 | 112.1 ± 17.7 | 37.6 ± 13.5 | 65.8 ± 15.5 | 15.9 ± 9.4 | 11.4 ± 5.6 | 184.9 ± 73.8 | 15.0 ± 10.3 |
| T0 | 99.4 ± 16.1 | 113.7 ± 10.5 | 108.5 ± 9.7 | 34.9 ± 11.9 | 64.5 ± 8.7 | 15.7 ± 2.4 | 13.4 ± 4.8 | 196.8 ± 69.3 | 18.6 ± 9.1 |
| T2 | 98.7 ± 15.0 | 112.1 ± 9.1∗ | 107.8 ± 8.5 | 33.4 ± 11.5 | 65.3 ± 8.8 | 15.9 ± 2.4 | 13.3 ± 4.4 | 177.4 ± 49.6 | 17.0 ± 8.3 |
| T6 | 98.4 ± 15.5 | 112.1 ± 9.3 | 107.2 ± 8.3 | 33.0 ± 11.1# | 65.4 ± 8.9 | 16.1 ± 2.8 | 12.5 ± 4.2# | 184.1 ± 62.3 | 17.8 ± 8.2 |
| T0 | 94.7 ± 17.3 | 108.5 ± 10.2 | 108.5 ± 10.8 | 34.9 ± 9.9 | 59.8 ± 11.2 | 14.6 ± 3.3 | 12.4 ± 5.3 | 158.0 ± 76.5 | 12.4 ± 9.7 |
| T2 | 95.0 ± 17.0 | 107.3 ± 10.0 | 107.4 ± 10.4∗ | 34.7 ± 10.1 | 60.3 ± 11.0 | 14.9 ± 3.4 | 12.8 ± 5.6 | 154.3 ± 57.7 | 11.9 ± 8.2 |
| T6 | 94.6 ± 17.5 | 106.7 ± 9.3 | 107.4 ± 11.5 | 34.4 ± 11.4 | 60.2 ± 11.3 | 14.5 ± 3.0 | 12.4 ± 5.4 | 151.9 ± 59.2 | 12.0 ± 8.9 |
Data are presented as mean ± SD. Abbreviations: FM, fat mass; HIIT, high intensity intermittent exercise; HIIT-RM, high intensity intermittent exercise with possibility to modulation the duration of recovery; HC, hip circumference; LM, lean mass; MD, missing data; MICT, moderate intensity continuous exercise; WC, waist circumference. ∗: p < 0.016 between T2 and T0, #: p < 0.016 between T6 and T0.
Cardiorespiratory fitness throughout the study in the four groups of subjects.
| PPO | VO2peak | VO2peak | VO2peak | Heart Rate | RERpeak | La | PO VT1 | PO VT2 | P Lipox max | MFO | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| watts | L.min−1 | mL.kg−1.min−1 | % predicted | bpm | mmol.L−1 | watts | watts | watts | mg.min−1 | ||
| T0 | 179 ± 79 | 2.48 ± 0.88 | 23.2 ± 6.1 | 118.0 ± 26.6 | 159 ± 14 | 1.05 ± 0.06 | 8.3 ± 1.8 | 115 ± 48 | 146 ± 71 | 77 ± 51 | 233.7 ± 135.9 |
| T2 | 191 ± 79∗ | 2.61 ± 0.88 | 24.4 ± 5.8∗ | 125.6 ± 27.1∗ | 154 ± 19 | 1.05 ± 0.05 | 7.7 ± 1.8 | 123 ± 46 | 159 ± 70∗ | 87 ± 43 | 264.3 ± 149.2 |
| T6 | 186 ± 75 | 2.50 ± 0.85 | 24.0 ± 6.0 | 122.8 ± 16.1 | 154 ± 21 | 1.05 ± 0.05 | 8.2 ± 1.9 | 121 ± 48 | 154 ± 72 | 87 ± 57 | 228.6 ± 128.5 |
| T0 | 176 ± 39 | 2.56 ± 0.58 | 23.8 ± 5.6 | 117.9 ± 25.3 | 165 ± 11 | 1.04 ± 0.07 | 8.9 ± 2.2 | 109 ± 28 | 139 ± 27 | 73 ± 19 | 219.4 ± 88.6 |
| T2 | 199 ± 42∗ | 2.78 ± 0.56∗ | 26.5 ± 5.5∗ | 131.5 ± 24.6∗ | 162 ± 13 | 1.05 ± 0.05 | 9.0 ± 1.2 | 128 ± 31∗ | 161 ± 34∗ | 91 ± 27 | 241.9 ± 81.3 |
| T6 | 185 ± 33 | 2.61 ± 0.49$ | 24.9 ± 5.1 | 124.0 ± 23.4# | 160 ± 13 | 1.05 ± 0.05 | 8.8 ± 2.4 | 126 ± 26# | 156 ± 29# | 80 ± 23 | 206.3 ± 63.1 |
| T0 | 163 ± 25 | 2.47 ± 0.46 | 23.3 ± 3.1 | 120.0 ± 15.8 | 163 ± 13 | 1.06 ± 0.07 | 8.8 ± 1.8 | 114 ± 20 | 133 ± 23 | 73 ± 24 | 217.7 ± 71.5 |
| T2 | 191 ± 39∗ | 2.71 ± 0.51∗ | 26.4 ± 4.0∗ | 137.3 ± 19.5∗ | 166 ± 14 | 1.05 ± 0.06 | 8.8 ± 1.8 | 124 ± 25 | 150 ± 36∗ | 76 ± 24 | 211.3 ± 66.8 |
| T6 | 175 ± 38 | 2.59 ± 0.50 | 24.9 ± 5.4 | 129.3 ± 24.0# | 160 ± 15 | 1.05 ± 0.07 | 8.4 ± 1.5 | 117 ± 24 | 145 ± 34# | 73 ± 18 | 205.6 ± 87.8 |
Data are presented as mean ± SD. Abbreviations: HIIT, high intensity intermittent exercise; HIIT-RM, high intensity intermittent exercise with possibility to modulation the duration of recovery; La, blood lactate concentration; MD, missing data; MICT, moderate intensity continuous exercise; MFO, maximal fat oxidation; P Lipoxmax, power at Lipoxmax; PPO, peak power output; PO VT1, power output at ventilatory threshold 1; PO VT, power output at ventilatory threshold 2; RER, respiratory exchange ratio; VO2 peak, peak oxygen consumption. ∗: p < 0.016 between T2 and T0, $: p < 0.016 between T6 and T2, #: p < 0.016 between T6 and T0.
Biological variables and vascular function.
| TC | Triglycerides | HDL | LDL | TC/HDL | hs-CRP | Glycemia | Insulin | HOMA2-IR | HOMA2-%S | HOMA2-%B | PAT | PWV | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| g.L−1 | g.L−1 | g.L−1 | g.L−1 | g.L−1 | mg.L−1 | mmol.L−1 | μUI. mL−1 | % | % | m.s−1 | |||
| T0 | 1.89 ± 0.38 | 1.58 ± 1.06 | 0.46 ± 0.12 | 1.17 ± 0.37 | 4.46 ± 1.75 | 5.05 ± 7.44 | 5.67 ± 1.03 | 12.5 ± 5.6 | 1.7 ± 0.8 | 73.3 ± 35.8 | 104.7 ± 29.5 | 2.1 ± 0.5 | 7.7 ± 1.1 |
| T2 | 1.81 ± 0.33 | 1.48 ± 0.98 | 0.46 ± 0.13 | 1.12 ± 0.40 | 4.24 ± 1.42 | 3.57 ± 4.76 | 5.72 ± 0.85 | 12.8 ± 7.7 | 1.7 ± 1.0 | 75.5 ± 46.3 | 110.0 ± 45.2 | 2.0 ± 0.5 | 7.4 ± 0.9 |
| T6 | 1.86 ± 0.37 | 1.52 ± 0.88 | 0.46 ± 0.11 | 1.15 ± 0.36 | 4.29 ± 1.31 | 2.70 ± 2.68 | 5.56 ± 0.95 | 10.7 ± 5.2# | 1.4 ± 0.7# | 91.5 ± 51.8# | 95.1 ± 25.8 | 1.9 ± 0.4 | 7.3 ± 0.9 |
| T0 | 2.04 ± 0.40 | 1.46 ± 0.61 | 0.49 ± 0.10 | 1.23 ± 0.37 | 4.22 ± 1.03 | 2.12 ± 1.99 | 5.92 ± 0.92 | 11.5 ± 5.3 | 1.5 ± 0.7 | 79.7 ± 37.7 | 91.1 ± 33.8 | 2.1 ± 0.6 | 8.8 ± 1.7 |
| T2 | 2.02 ± 0.33 | 1.50 ± 0.61 | 0.47 ± 0.10 | 1.22 ± 0.28 | 4.40 ± 0.99 | 1.94 ± 1.83 | 6.46 ± 1.56 | 10.7 ± 4.1 | 1.5 ± 0.6 | 79.9 ± 36.7 | 78.2 ± 32.8 | 2.0 ± 0.3 | 8.0 ± 1.3 |
| T6 | 2.00 ± 0.28 | 1.24 ± 0.56 | 0.51 ± 0.12 | 1.23 ± 0.23 | 4.09 ± 0.95 | 1.85 ± 1.82 | 5.93 ± 0.82 | 14.1 ± 9.9 | 1.9 ± 1.3 | 80.0 ± 46.0 | 98.8 ± 44.3 | 1.9 ± 0.5 | 8.4 ± 0.9 |
| T0 | 1.94 ± 0.46 | 1.36 ± 0.57 | 0.53 ± 0.12 | 1.17 ± 0.42 | 3.83 ± 0.84 | 2.62 ± 2.99 | 5.44 ± 0.57 | 11.2 ± 6.2 | 1.6 ± 0.7 | 82.6 ± 45.1 | 106.4 ± 41.1 | 2.1 ± 0.6 | 7.8 ± 1.0 |
| T2 | 1.96 ± 0.47 | 1.52 ± 1.06 | 0.53 ± 0.12 | 1.18 ± 0.42 | 3.86 ± 1.02 | 2.27 ± 1.50 | 5.43 ± 0.70 | 9.1 ± 4.3 | 1.3 ± 0.5 | 100.1 ± 58.2 | 94.5 ± 42.0 | 2.2 ± 0.6 | 7.7 ± 1.0 |
| T6 | 2.02 ± 0.55 | 1.25 ± 0.52 | 0.52 ± 0.11 | 1.27 ± 0.47 | 3.97 ± 0.98 | 1.90 ± 1.37 | 5.56 ± 0.60 | 10.2 ± 6.0 | 1.4 ± 0.8 | 112.6 ± 114.6 | 92.9 ± 40.6 | 2.2 ± 0.6 | 8.0 ± 1.6 |
Data are presented as mean ± SD. Abbreviations: HDL, high density lipoprotein; HIIT, high intensity intermittent exercise; HIIT-RM, high intensity intermittent exercise with possibility to modulation the duration of recovery; HOMA, homeostasis model assessment of insulin resistance; hs-CRP, high-sensitive C-reactive protein; LDL, low density lipoprotein; MD, missing data; MICT, moderate intensity continuous exercise; PAT, peripheral arterial tone; PWV, pulse wave velocity; TC, total cholesterol; TC/HDL, ratio between total cholesterol and high density lipoprotein; #: p < 0.016 between T6 and T0.
Spontaneous physical Activity and sleep variables.
| Steps/d | EE | EE | ST | LPA | M-VVPA | Sleep duration | Time lying down | Sleep efficiency | |
|---|---|---|---|---|---|---|---|---|---|
| n | kcal | MET | min | min | min | min | min | % | |
| T0 | 7473 ± 3607 | 3042 ± 685 | 1.24 ± 0.19 | 1045 ± 125 | 202 ± 70 | 92 ± 62 | 391 ± 87 | 444 ± 161 | 84 ± 4 |
| T2 | 7822 ± 3603 | 3066 ± 717 | 1.23 ± 0.18 | 1094 ± 83 | 199 ± 61 | 93 ± 53 | 398 ± 72 | 477 ± 75 | 83 ± 7 |
| T6 | 6270 ± 2583 | 2849 ± 673 | 1.23 ± 0.19 | 1033 ± 200 | 159 ± 86 | 82 ± 53 | 410 ± 74 | 484 ± 78 | 84 ± 4 |
| T0 | 8796 ± 1690 | 2926 ± 622 | 1.31 ± 0.25 | 1048 ± 144 | 253 ± 109 | 93 ± 65 | 364 ± 129 | 457 ± 195 | 81 ± 7 |
| T2 | 7759 ± 3516 | 2732 ± 340 | 1.38 ± 0.54 | 1067 ± 138 | 208 ± 135 | 94 ± 83 | 393 ± 104 | 486 ± 144 | 82 ± 8 |
| T6 | 7920 ± 3579 | 2871 ± 561 | 1.41 ± 0.32 | 1045 ± 136 | 195 ± 112 | 105 ± 90 | 396 ± 129 | 501 ± 187 | 80 ± 10 |
| T0 | 9642 ± 1906 | 2695 ± 589 | 1.32 ± 0.17 | 1055 ± 85 | 269 ± 46 | 91 ± 51 | 384 ± 24 | 459 ± 38 | 84 ± 6 |
| T2 | 9813 ± 3552 | 2639 ± 687 | 1.42 ± 0.37 | 1029 ± 84 | 268 ± 32 | 83 ± 70 | 372 ± 65 | 444 ± 88 | 84 ± 5 |
| T6 | 9869 ± 2863 | 2757 ± 587 | 1.42 ± 0.27 | 1068 ± 76 | 225 ± 67 | 127 ± 66 | 387 ± 71 | 473 ± 91 | 82 ± 8 |
Data are presented as mean ± SD. Abbreviations: EE, daily energy expenditure; HIIT, high intensity intermittent exercise; HIIT-RM, high intensity intermittent exercise with possibility to modulation the duration of recovery; LPA, daily light physical activity; MD, missing data; MICT, moderate intensity continuous exercise; M-VVPA, daily moderate to very vigorous physical activity; ST, sedentary time.
Fig. 2Changes in VO2peak (% predicted) from T0 to T2 in the three groups (MICT: moderate intensity continuous exercise; HIIT: high intensity intermittent exercise; HIIT-RM: high intensity intermittent exercise with possibility to modulate the duration of recovery); T0: baseline; T2: after 2 months of training. Significant differences between groups: ∗p < 0.016.
Fig. 3Changes in VO2peak (% predicted) from T2 to T6 in the three groups (MICT: moderate intensity continuous exercise; HIIT: high intensity intermittent exercise; HIIT-RM: high intensity intermittent exercise with possibility for the subject to modulate the duration of recovery). T2: after 2 months of training, T6: Four months after supervised program.
Fig. 4Comparison of variations in moderate to very vigorous physical activity between T6 and T2 in the 2 exercise groups (MICT: moderate intensity continuous exercise; HIIT: high intensity intermittent exercise). T2: after 2 months of training, T6: Four months after supervised program.